Hyderabad-based Biolegical E opens new Rs 300-crore vaccine facility

Biological E received the authorisation from the Central Drugs Standard Control Organisation for Typhoid conjugate vaccine

Hyderabad-based vaccine company Biological E Limited (BE) has opened a new Rs 300-crore plant for increasing the production of its existing portfolio of vaccines and manufacture new products which are in pipeline. The plant would employ around 1,000 people, according to the company. The company also unveiled its new Typhoid conjugate vaccine (TCV) on Monday.

Recently, BE received the authorisation from the Central Drugs Standard Control Organisation (CDSO) for the TCV, which was developed in partnership with GSK Vaccines Institute for Global Health.

"We are happy that our joint efforts have successfully produced a promising Typhoid vaccine. This is a